Ledger.Open graph →
SEC Form D · filed July 18, 2013

Loxo Oncology, Inc

Offering
—
Sold
$10.0M
Exemption
—
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

People & firms on this filing (3)

Joshua H. Bilenker · New York, NYExec · DirectorSteven Elms · The Woodlands, TXDirectorDov Goldstein · New Yotk, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗